Literature DB >> 18569240

Experiences of Institutional Review Board (IRB) and Protocol Review and Monitoring Committee (PRMC) rotations in hematology/oncology training.

Andrea Wang-Gillam1, Jimmie Valentine, Allen C Sherman, Paulette Mehta.   

Abstract

BACKGROUND: Trainees in hematology oncology need to learn development and regulation of clinical research protocols.
METHODS: We hypothesized that rotation on the Institutional Review Board (IRB) and Protocol Review and Monitor Committee (PRMC) at our university could improve fellows' understanding of clinical trial development and regulation.
RESULTS: Since 1999, 20 fellows in our training program have rotated through either IRB or PRMC for 3 months. We evaluated their experiences by anonymous questionnaire with 13 quantitative, 1 yes-or-no, and 4 open-ended questions and correlated responses to their demographic characteristics.
CONCLUSIONS: We report here these fellow's experiences in attending these meetings. We also describe other benefits of IRB/PRMC participation in training fellows, and finally propose to other fellowship programs to consider this educational approach as a way of enhancing hematology/oncology training.

Mesh:

Year:  2008        PMID: 18569240     DOI: 10.1080/08858190701818242

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  4 in total

1.  Protecting human subjects in research: the role of the IRB.

Authors:  B Rogers
Journal:  AAOHN J       Date:  1992-10

2.  Searching for an efficient institutional review board review model: Interrelationship of trainee-investigators, funding, and initial approval.

Authors:  Roberto A Dominguez; Daniel J Feaster; Leo B Twiggs; Norman H Altman
Journal:  J Lab Clin Med       Date:  2005-02

3.  Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group.

Authors:  Y Nancy You; Kelly K Hunt; Mitchell C Posner; Joe B Putnam; Heidi Nelson; David M Ota; Peter W T Pisters
Journal:  Surgery       Date:  2006-04       Impact factor: 3.982

4.  Impact of institutional review boards on cancer research.

Authors:  B J Kennedy
Journal:  J Bioeth       Date:  1984 Spring-Summer
  4 in total
  1 in total

1.  Insight into early-phase trials for lung cancer in the United States.

Authors:  Jin-Ji Yang; Yi-Long Wu
Journal:  Chin J Cancer       Date:  2015-07-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.